Trial Profile
The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Atorvastatin/metformin (Primary)
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 07 Mar 2015 Status changed from recruiting to completed as per the abstract presented at the 116th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 18 Jun 2014 New trial record